Skip to main content
Clinical Trials/CTRI/2018/05/014095
CTRI/2018/05/014095
Recruiting
Phase 1

Development of a Computerized Neurocognitive Remediation Package And Phase II Trial For Assessment Of Its Efficacy In Cognitive Function Among Patients With Schizophrenia

All India Institute of Medical Sciences0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: null- Schizophrenia
Sponsor
All India Institute of Medical Sciences
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male or female between 18\-45 years of age
  • Meeting the DSM\-5 clinical criteria for schizophrenia (APA, 2013\)
  • Patients currently stabilized on same antipsychotics for a period of at least 6 weeks
  • Patients or primary caregiver with capacity and willingness to give informed consent.
  • Both in\-patients and out\-patients
  • Having basic familiarity \& comfort with using computers
  • Both Right and Left Handed
  • Education up to Primary level

Exclusion Criteria

  • Presence of past or current co\-morbid Axis I disorders including substance abuse/dependence (other than caffeine or nicotine)
  • Any history of seizure EXCEPT those therapeutically induced by ECT
  • History suggestive of any neurological or progressive neurological condition.
  • Having Colour blindness or Blindness
  • Hearing impairment
  • Non\-consenting individuals
  • Visual or motor disability which may hinder use of computers.

Outcomes

Primary Outcomes

Not specified

Similar Trials